Giovanni Amabile

Previously CEO at Enthera35 M Euros Raised in Seed and Series A Previously CSO at ADIENNE Pharma Proven ability to develop investigational drugs Successful Track Record to lead trials and receive MA approvals in US Strong Regulatory Expertise in US and EU Successful Track Record to receive IND approvals Proven ability to transform startupsinto clinical stage company Author of several high impact publications including Nature, Cancer Cell, Nat Cell Biol